Henry Schein (NASDAQ:HSIC) issued its quarterly earnings results on Thursday. The company reported $0.97 EPS for the quarter, beating the Zacks’ consensus estimate of $0.91 by $0.06, Bloomberg Earnings reports. The business had revenue of $2.67 billion for the quarter, compared to analysts’ expectations of $2.64 billion. Henry Schein had a net margin of 4.66% and a return on equity of 15.93%. The business’s quarterly revenue was up 7.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.12 earnings per share. Henry Schein updated its FY 2020
Pre-Market guidance to 3.65-3.75 EPS and its FY20 guidance to $3.65 to $3.75 EPS.
Shares of HSIC stock traded down $4.79 on Thursday, reaching $68.92. 3,952,484 shares of the company were exchanged, compared to its average volume of 1,026,793. The company has a market cap of $10.71 billion, a price-to-earnings ratio of 20.76, a PEG ratio of 2.22 and a beta of 0.85. The company has a 50-day moving average of $69.54 and a 200-day moving average of $65.92. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.63 and a quick ratio of 0.92. Henry Schein has a one year low of $56.58 and a one year high of $73.99.
HSIC has been the topic of a number of research analyst reports. Evercore ISI cut shares of Henry Schein from an “in-line” rating to an “underperform” rating in a research report on Friday, January 3rd. Cleveland Research reaffirmed a “hold” rating on shares of Henry Schein in a research report on Friday, November 1st. Barrington Research reaffirmed a “buy” rating and set a $75.00 price target on shares of Henry Schein in a research report on Wednesday, November 6th. ValuEngine cut shares of Henry Schein from a “sell” rating to a “strong sell” rating in a research report on Monday, February 10th. Finally, Robert W. Baird cut shares of Henry Schein from an “outperform” rating to a “neutral” rating in a research report on Thursday, January 2nd. Five research analysts have rated the stock with a sell rating, seven have assigned a hold rating and five have issued a buy rating to the company’s stock. Henry Schein has a consensus rating of “Hold” and an average price target of $70.50.
Henry Schein Company Profile
Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Featured Story: S&P 500 Index
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.